Thursday, December 20, 2018

Global Natural Sausage Casings Market Will Reach USD 3,090.1 million by 2022


Natural Sausage Casings Market is segmented by source (hog, beef, sheep, and others) and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) – Global Forecast (2017-2022)
Global Natural Sausage Casings Market has not only managed to sustain threats from artificial casings but has shown steady growth pattern in recent years due to consumer preference to natural casings over artificial casings, growing meat production & consumption across the globe, increasing population & urbanization, and rising number of fast food restaurant chains. In addition, emerging economies such as Latin America, South East Asia, and Africa provides significant opportunities for the manufacturers in the global natural casings market which ensures positive prospects for this market in near future.
Meticulous Research® in its latest publication on Natural Sausage Casings Market states that the global natural casings market will increase at a CAGR of 3.4% from 2017 to 2022 to $3,090.1 million by 2022.
Wherein, geographically, Europe marginally beats the North America in terms of market share. The growth in the European natural casings market is primarily attributed to the increasing population, growing fast food industry, increasing meat production & consumption, and presence of large number of sausages & casings manufacturers.

The report provides meticulous analysis of global Natural Sausage Casings Market by segmenting it on the basis of sources. Wherein, it analyzes casings made from the natural sources such as sheep, goats, lambs, pigs, cattle, and horses. The casings made from hog holds major market share primarily due to increasing pork sausage production and consumption, and increasing westernization & urbanization in developing countries, especially China where hog sausages are getting more popular. However, some religious considerations such as Jews & Muslims that avoid hog/pig consumption in any form pose a serious challenge to hog casings.
The key players analyzed in the global Natural Sausage Casings Market are Amjadi GmbH, Combinatie Teijsen V.D. Hengel(CTH), Almol (Australia) Casing Pty Ltd, World Casings Corporation, Natural Casings Company Inc., DAT-Schaub Group, Saria Se And Co. Kg, De Wied International Inc., PeterGelhard Naturdärme KG, Oversea Casing Company LLC., A Holdijk GmbH, Agrimares group, Carl Lipmann & Co. KG, Fortis Natural Casings, Irish Natural Casing Company, MCJ Casings, CDS Hackner GmbH, Saarland Metzgereibedarf Strobel GmbH & Co. KG., Rugao Qingfeng Casing co., ltd, and Baoding Huilin Group, and Elshazly Casings Company.
Key Topics Covered in This Report:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Global Natural Casings Market, by Source
6. Global Natural Casings Market, By Geography
7 Competitive Landscape
8 Company Profiles (Business Overview, Recent Financials, Product Portfolio, and Recent Strategic Developments)
9. Appendix.     
                    Click Here To Download Free Sample Report Immediately
                     https://www.meticulousresearch.com/download-sample-report/
Contact -
Viren Shrivastava
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)


Monday, December 17, 2018

Nematicides Market is set to grow at a CAGR of 3.0% to reach USD 1,344.5 million by 2023


Meticulous Research®, leading global market research company published a research report titled, “The Global Nematicides Market is projected to USD 1,344.5 million by 2023 growing at a CAGR of 3.0% during the forecast period of 2018 to 2023.”

Nematicides Market by Type (chemical and biological), by chemical type (fumigants, carbamates, and organophosphates), by formulation (liquid form and solid form), by mode of application (fumigation, irrigation, spraying, and seed treatment), and by crop type (fruits & vegetables, oilseeds, grains & cereals, and others) – Global Opportunity Analysis and Industry Forecast (2018 – 2023)

The study offers a comprehensive analysis of global Nematicides Market with respect to various product types, formulation, application, and crop type. The global nematicides market is mainly segmented by product type (chemical and biological), chemical type (fumigants, carbamates, and organophosphates), form (liquid and solid), mode of application (fumigation, irrigation, spraying, and seed treatment), crop type (fruits & vegetables, oilseeds, cereals & grains, and other crops), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Based on product type, chemical nematicides commanded the largest share in this market in 2017, owing to its increasing usage in developing countries, easy availability, higher efficiency, and low cost as compared to biologicals. However, the biological nematicides expected to witness the fastest growth during the forecast period, mainly due to growing environmental and public health concerns with the use of chemical nematicides, growing organic farming, increasing demand for chemical residue free agricultural products, and government support to use biological nematicides treatment across the globe.
The key players operating in the global nematicides market are Bayer CropScience AG, BASF SE, The Dow Chemical Company, Syngenta, FMC Corporation, Sumitomo Chemical Co., Ltd., Monsanto Company, Nufarm Limited, ADAMA Agricultural Solutions Ltd., AMVAC Chemical Corporation, Brandt Consolidated, Inc., Isagro S.p.A., Marrone Bio Innovations Inc., and Certis USA L.L.C.
                        Hurry Up Limited Period Offer To Get Free Sample Report Now !!           

          
Scope of the Report
Market by Product Type
·         Chemical
·         Fumigants
·         Carbamates
·         Organophosphate
·         Biological 
Market by Form
·         Liquid form
·         Solid form
Market by Mode of Application
·         Fumigation
·         Irrigation
·         Spraying
·         Seed Treatment              
Market by Crop Type
·         Fruits and Vegetables
·         Oilseeds
·         Cereals & Grains
·         Other Crops
                             TOP 10 COMPANIES IN GLOBAL NEMATICIDES MARKET
Market by Geography
·         North America
·         U.S.
·         Canada
·         Mexico
·         Europe
·         Spain
·         Italy
·         Germany
·         France
·         Rest of Europe
·         Asia-Pacific
·         Japan
·         China
·         India
·         Rest of Asia-Pacific
·         Rest of World
·         Latin America
·         Brazil
·         Argentina
·         Chile
·         Rest of LATAM
·         Middle East & Africa
The report also includes the competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017). The study has also incorporated the detailed profiles of 14 top market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.           
                              Click Here To Download Free Sample Report Immediately

Contact -
Viren Shrivastava
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)


Thursday, December 13, 2018

Molecular Cytogenetics Market Worth 2,266.4 Million USD By 2022


Meticulous Research®, leading global market research company published a research report titled, “The Global Molecular Cytogenetics Market is projected to reach $2,266.4 million by 2022 growing at a CAGR of 11.0% during the forecast period of 2017 to 2022.”

This growth is primarily driven by the increasing focus on preventive healthcare measures, increasing genetic abnormalities; growing aging population and subsequent increase in chronic diseases, increasing need to reduce mounting healthcare cost, and rising focus on clinical and research diagnosis.

Molecular cytogenetics plays an important role in diagnosis of various diseases. Based on the type of diseases, the diagnosis can be possible using various cytogenetic techniques such as Fluorescence In Situ Hybridization (FISH), In Situ Hybridization, Karyotyping, Banding Techniques, and others. The banding techniques have been used since past decades because of their easy accessibility and availability. However, due to its drawbacks in identifying genetic diseases at submicroscopic level, it is further modified into in situ hybridization. Currently, the FISH plays a major role in diagnosis of various diseases at genetic level using advanced molecular cytogenetic products.

FISH is mainly used to detect the chromosomal aberrations such as deletion, duplication, insertion, and gene expression. It can be applicable to any specimen. Also, it is suitable for heterogeneous breakpoints or multiple translocation patterns. However, it has less sensitivity for detecting the genetic abnormality and requires expertise to interpret the results as there is a risk of getting false positive results. However, with the growing need to diagnose diseases at molecular level, array-based technologies have emerged and preferred over FISH technique.
Read full Research Report Study On 

Array based techniques are preferred over FISH since the high resolution, locus specific analysis, and genome wide evaluation are combined in a single technique. Also, the sensitivity of these techniques is high compared to FISH which is useful for researchers in the detection of microdeletions. The array-based techniques are used in detection of any type of cancers since they are able to screen whole genome variations compared to FISH. The microarray uses 1000 probes at a time, whereas FISH uses only one probe. The use of these many probes at a time makes the diagnosis easy and quick. This technique is also useful in the detection of abnormalities in all 24 chromosomes, whereas FISH has limit up to 12 chromosomes.


The report provides meticulous analysis of Molecular Cytogenetics Market on the basis of technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), product (instruments, kits and reagents, software, services, and consumable/accessories), application (oncology, genetic disorders, personalized medicines, and other), end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes), and geography.

The use of array is mostly in detection of copy number variations which is not applicable for FISH. Thus, because of the number of benefits provided by array-based techniques, their use by various end users is increasing for both qualitative and quantitative detection of genetic diseases. These techniques not only improve the sensitivity of diagnosis but also the accuracy of results. This transition helps in use of diagnostic products to large extent.

The major companies such as Thermo Fisher Scientific, Illumina Inc., Agilent Technologies, and Oxford Gene Technology are manufacturing array-based products in order to accelerate research. They are providing sophisticated technology for running thousands of samples at a time to analyze genetic variations efficiently.
Hurry Up To Get Your Free Sample Report Now!

The key players analyzed in the molecular cytogenetics market are Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Bio-Rad Laboratories (U.S.), Applied Spectral Imaging (U.S.), Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland) , Danaher Corporation (U.S.), Illumina (U.S.), and Oxford Gene Technology (U.S.).

Contact -
Viren Shrivastava
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)


Wednesday, December 12, 2018

Diabetes Care Devices Market Worth 26,710.3 Million USD By 2022

Meticulous Research®, leading global market research company published a research report titled, “The Global Diabetes Care Devices Market is projected to $26,710.3 million by 2022 growing at a CAGR of 5.3% during the forecast period of 2017 to 2022.”

The significant growth in diabetes population is primarily attributed to the rising obesity rates across the globe, and increasing sedentary lifestyle with poor diets and lowered physical inactivity. According to the World Health Organization (WHO), in 2014, around 39% adults were overweight. Of these about 13% of the world’s adult population were obese; and almost half the world will be overweight or obese by 2030. With increasing levels of obesity and physical inactivity among children in many countries, type 2 diabetes in childhood has the potential to become a global public health issue, leading to serious health outcomes. The ignorance of the diabetes at early stage can lead to many severe complications, including increased risk of cardiovascular diseases and kidney disorders and thereby huge financial implications.




Thus, the rising diabetic population across the globe will propel the number of people who must be monitored with the periodic monitoring of their blood glucose, thereby leading to a growing demand for diabetes care devices.

Diabetes Care Devices Market by Monitoring Devices (Test Strips, Self-Monitoring Devices, CGM Devices, Lancets, Hemoglobin A1c Testing Kits) and Insulin Delivery Devices (Insulin Pens, Insulin Syringes, Insulin Pumps, Insulin Jet Injectors) – Global Opportunity Analysis and Industry Forecast To 2022.

Read full Research Report Study On

Global Diabetes Care Devices Market is driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. Moreover, various developments of new technologies for the delivery of insulin further provide significant opportunities in this market. However, high cost associated with the diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of diabetes care devices market to some extent.


Scope of the Report
Market by Type
Diabetes monitoring devices
– Test strips
– Self-monitoring devices
– Continuous blood glucose monitoring devices
– Lancets
– Hemoglobin A1c testing kits

Insulin delivery devices
– Insulin Pens
– Insulin Syringes
– Insulin Pumps
– Insulin Jet Injector

The insulin pens held the largest share of the global insulin delivery devices market in 2016, mainly due to their rising adoption with several advantages over the traditional syringe method of insulin delivery, including improved patient satisfaction and adherence, user-friendliness, superior accuracy for delivering small doses of insulin, greater social acceptability, and less reported injection pain.

The key players in the global diabetes care devices market are Novo Nordisk A/S, Ypsomed AG, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic, Becton, Dickinson and Company, Terumo Corporation, and Sanofi AS.

Hurry Up To Get Your Free Sample Report Now!

Contact -
Viren Shrivastava
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)